Hints and tips:
...It was unbelievable,” said Alisha Alaimo, Biogen’s North America head....
...Joshua Ma, who ran TikTok Shop in Europe, stepped down from his role after it was revealed he told staff that he “didn’t believe” in maternity leave but remains at the company....
...Ma stepped down from his role following the revelation but remains at the company....
...In 2022, the Financial Times reported that Joshua Ma, who had been leading TikTok’s European ecommerce team, told staff at a dinner that he “didn’t believe” in maternity leave....
...Some added that Li and his wife Melissa Ma’s joint presence at the company caused issues for subordinates. The company declined to make Li or Ma available for an interview....
...The investigation into Ma’s comments concluded several weeks ago and the recommended disciplinary actions had been taken, TikTok said....
...MA has been the industry’s growth area....
...Demaré declined to comment directly on the Biogen talks, but said that at the far larger AstraZeneca Soriot could create “a few Biogens in the years to come”. Biogen declined to comment on the talks....
...Last Wednesday, Tan secured a seat next to vice-foreign minister Ma Zhaoxu at a lavish dinner American businesses put on for the Chinese president, according to photos and people familiar with the matter...
...Its decision against widely covering Aduhelm, another Alzheimer’s drug developed by Biogen and Eisai, which secured a form of conditional approval two years ago, contributed to Biogen scrapping its commercial...
...This move should unify things,” said Duncan Clark, founder of the Beijing-based BDA China consultancy and author of Alibaba: The House That Jack Ma Built....
...From a new NBER working paper titled Monetary Policy and Innovation by Yueran Ma of the University of Chicago and Kaspar Zimmerman of the Frankfurt School of Finance: We document that monetary policy has...
...Suggested reads Chinese fintech Ant Group targets global growth after Jack Ma’s exit (FT) Japan outspends US, Germany on chip subsidies as share of GDP (Nikkei Asia) The Steve Jobs of China turns car...
...But he gave up those roles to two longtime confidantes of Ma earlier this year as part of a major restructuring of the group....
...Biogen later dropped the price to $28,200, according to the report....
...The US Food and Drug Administration in January approved lecanemab, a drug co-developed by Japanese drugmaker Eisai and US biotech Biogen, under an accelerated process....
...Investors responded by bidding up Biogen and Eisai shares by 47 per cent and 66 per cent respectively....
...Christopher Viehbacher, Biogen’s chief executive, told an audience at a biotech conference in Boston that the company would look at whether it should file its own lawsuit against the IRA....
...Shares in Biogen and Eisai surged on Wednesday after the pharma groups said they would apply for regulatory approval for a new Alzheimer’s drug following a late-stage clinical trial that showed it slowed...
...A genetically targeted treatment for motor neurone disease developed by Biogen has slowed the progression of the disease in a clinical trial and even improved the symptoms of some patients....
...Ma Ka says the impact of stricter enforcement of censorship rules is clear with Honkai: Star Rail....
...The company said it accepted the MAS decision on lapses....
...Both Roche’s gantenerumab and lecanemab, co-developed by Eisai and Biogen, are monoclonal antibody treatments based on the hypothesis....
...Lecanemab originated with BioArctic, a small Swedish company that collaborated with Eisai and then Biogen to take it through clinical trials....
...Jack Ma in Tokyo Jack Ma, the Alibaba founder and once the richest business leader in China, has been living in central Tokyo for nearly six months, amid Beijing’s ongoing crackdown on the country’s technology...
International Edition